Diabetic nephropathy is one of the most serious complications of diabetes mellitus. It is not only a central cause of terminal renal insufficiency, but is also closely linked to cardiovascular morbidity and mortality. The search for modifiable risk factors is therefore of the utmost relevance. A recent meta-analysis updates and clarifies the data situation and shows that both current and former smoking are associated with a significantly increased risk for the development and progression of diabetic nephropathy. This has far-reaching implications for nephrology practice – in risk stratification, monitoring and preventive counseling.
You May Also Like
- Autoimmune Liver Diseases
Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New?
- Myelofibrosis
Mutations and Molecular Diagnostics in Treatment Decisions
- Psoriasis in the Age of Precision Medicine
Systemic Therapy for Patients with Comorbidities: What Is the Best Choice?
- The AMALFI study and the limits of digital screening for atrial fibrillation
Remote monitoring for atrial fibrillation: lots of detection, little stroke prevention?
- MASH
Pharmacotherapies as “Game Changers”—What Are the Upcoming Challenges?
- Obesity Treatment
Oral GLP-1 Therapies: ATTAIN-1 and OASIS-4—The Next Leap Forward
- Older patients with atopic dermatitis
Why the Use of Biologics Is Recommended
- Disorders of the Gut-Brain Interaction